Sophia Genetics

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$21,688
$21,707
$19,462
$18,323
Gross Profit
14,749
14,692
12,907
12,270
EBITDA
-14,532
-15,611
-17,243
-18,723
EBIT
-17,283
-18,049
-18,338
-21,093
Net Income
-19,322
-19,179
-20,021
-22,414
Net Change In Cash
21,688
21,707
19,462
18,323
Free Cash Flow
-17,057
-9,283
-8,899
-10,190
Cash
65,391
70,289
81,610
94,822
Basic Shares
71,137
68,241
67,787
67,321

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$77,271
$65,173
$62,371
$47,560
Gross Profit
47,814
43,937
42,913
31,254
EBITDA
-61,396
-50,761
-69,571
-81,375
EBIT
-70,925
-59,357
-77,907
-86,946
Net Income
-78,999
-62,493
-78,981
-87,449
Net Change In Cash
77,271
65,173
62,371
47,560
Free Cash Flow
-38,585
-50,998
-57,801
-80,474
Cash
70,289
80,226
123,251
161,305
Basic Shares
67,539
65,782
64,750
64,099

Earnings Calls

QuarterEPS
2026-03-31
-$0.19
2025-12-31
-$0.17
2025-09-30
-$0.30
2025-06-30
-$0.24